Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)

NCT00517491 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Administrative reasons

Conditions

Acromegaly

Interventions

DRUG: lanreotide (Autogel formulation)

Sponsor

Ipsen